BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24830713)

  • 1. Molecular docking and fluorescence characterization of benzothieno[3,2-d]pyrimidin-4-one sulphonamide thio-derivatives, a novel class of selective cyclooxygenase-2 inhibitors.
    Barone M; Pannuzzo G; Santagati A; Catalfo A; De Guidi G; Cardile V
    Molecules; 2014 May; 19(5):6106-22. PubMed ID: 24830713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, biological evaluation and docking study of maleimide derivatives bearing benzenesulfonamide as selective COX-2 inhibitors and anti-inflammatory agents.
    Firke SD; Bari SB
    Bioorg Med Chem; 2015 Sep; 23(17):5273-81. PubMed ID: 26277757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of Hydroxybenzofuranyl-pyrazolyl and Hydroxyphenyl-pyrazolyl Chalcones and Their Corresponding Pyrazoline Derivatives as COX Inhibitors, Anti-inflammatory and Gastroprotective Agents.
    Ragab FAE; Mohammed EI; Abdel Jaleel GA; Selim AAMAE; Nissan YM
    Chem Pharm Bull (Tokyo); 2020; 68(8):742-752. PubMed ID: 32741915
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring Anti-inflammatory Potential of Thiazolidinone Derivatives of Benzenesulfonamide via Synthesis, Molecular Docking and Biological Evaluation.
    Bari SB; Firake SD
    Antiinflamm Antiallergy Agents Med Chem; 2016; 15(1):44-53. PubMed ID: 27216235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel benzenesulfonamide and 1,2-benzisothiazol-3(2H)-one-1,1-dioxide derivatives as potential selective COX-2 inhibitors.
    Taher ES; Ibrahim TS; Fares M; Al-Mahmoudy AMM; Radwan AF; Orabi KY; El-Sabbagh OI
    Eur J Med Chem; 2019 Jun; 171():372-382. PubMed ID: 30928709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Syntheses and characterization of nimesulide derivatives for dual enzyme inhibitors of both cyclooxygenase-1/2 and 5-lipoxygenase.
    Li Y; Chen SH; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
    Bioorg Med Chem; 2011 Mar; 19(6):2074-83. PubMed ID: 21349729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular modeling, synthesis and screening of some new 4-thiazolidinone derivatives with promising selective COX-2 inhibitory activity.
    Unsal-Tan O; Ozadali K; Piskin K; Balkan A
    Eur J Med Chem; 2012 Nov; 57():59-64. PubMed ID: 23047224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective cyclooxygenase inhibition and ulcerogenic liability of some newly prepared anti-inflammatory agents having thiazolo[4,5-d]pyrimidine scaffold.
    Bakr RB; Ghoneim AA; Azouz AA
    Bioorg Chem; 2019 Jul; 88():102964. PubMed ID: 31075742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding the Dual Inhibition of COX-2 and Carbonic Anhydrase-II by Celecoxib and CG100649 Using Density Functional Theory Calculations and other Molecular Modelling Approaches.
    Singh O; Kakularam KR; Reddanna P; Aparoy P
    Protein Pept Lett; 2015; 22(10):903-12. PubMed ID: 26095375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, Synthesis and Comprehensive Investigations of Pyrrolo[3,4-
    Szczukowski Ł; Krzyżak E; Zborowska A; Zając P; Potyrak K; Peregrym K; Wiatrak B; Marciniak A; Świątek P
    Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33348757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, modeling studies and biological evaluation of thiazolidine derivatives containing pyrazole core as potential anti-diabetic PPAR-γ agonists and anti-inflammatory COX-2 selective inhibitors.
    Abdellatif KRA; Fadaly WAA; Kamel GM; Elshaier YAMM; El-Magd MA
    Bioorg Chem; 2019 Feb; 82():86-99. PubMed ID: 30278282
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis, biological evaluation and docking study of a new series of di-substituted benzoxazole derivatives as selective COX-2 inhibitors and anti-inflammatory agents.
    Kaur A; Pathak DP; Sharma V; Wakode S
    Bioorg Med Chem; 2018 Feb; 26(4):891-902. PubMed ID: 29373271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular design, synthesis and biological evaluation of cyclic imides bearing benzenesulfonamide fragment as potential COX-2 inhibitors. Part 2.
    Al-Suwaidan IA; Alanazi AM; El-Azab AS; Al-Obaid AM; ElTahir KE; Maarouf AR; Abu El-Enin MA; Abdel-Aziz AA
    Bioorg Med Chem Lett; 2013 May; 23(9):2601-5. PubMed ID: 23528298
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and biological evaluation of new nicotinate derivatives as potential anti-inflammatory agents targeting COX-2 enzyme.
    El-Dash Y; Khalil NA; Ahmed EM; Hassan MSA
    Bioorg Chem; 2021 Feb; 107():104610. PubMed ID: 33454504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celecoxib analogs bearing benzofuran moiety as cyclooxygenase-2 inhibitors: design, synthesis and evaluation as potential anti-inflammatory agents.
    Hassan GS; Abou-Seri SM; Kamel G; Ali MM
    Eur J Med Chem; 2014 Apr; 76():482-93. PubMed ID: 24607877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and pharmacological evaluation of novel and selective COX-2 inhibitors based on bumetanide scaffold.
    Ibrahim TS; Salem IM; Mostafa SM; El-Sabbagh OI; ElKhamisi MKM; Hegazy L; Elgendy B
    Bioorg Chem; 2020 Jul; 100():103878. PubMed ID: 32361486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New carboxamide derivatives bearing benzenesulphonamide as a selective COX-II inhibitor: Design, synthesis and structure-activity relationship.
    Ugwu DI; Okoro UC; Ahmad H
    PLoS One; 2017; 12(9):e0183807. PubMed ID: 28922386
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, Molecular Docking and Anticancer Activity of Diflunisal Derivatives as Cyclooxygenase Enzyme Inhibitors.
    Coşkun GP; Djikic T; Hayal TB; Türkel N; Yelekçi K; Şahin F; Küçükgüzel ŞG
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30082676
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring molecular docking with MM-GBSA and molecular dynamics simulation to predict potent inhibitors of cyclooxygenase (COX-2) enzyme from terpenoid-based active principles of
    Nayak A; Gadnayak A; Dash KT; Jena S; Ray A; Nayak S; Sahoo A
    J Biomol Struct Dyn; 2023 Dec; 41(20):10840-10850. PubMed ID: 36576262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis and biological evaluation of pyridine acyl sulfonamide derivatives as novel COX-2 inhibitors.
    Lu X; Zhang H; Li X; Chen G; Li QS; Luo Y; Ruan BF; Chen XW; Zhu HL
    Bioorg Med Chem; 2011 Nov; 19(22):6827-32. PubMed ID: 22000948
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.